Ocular, Visual, and Anatomical Outcomes in Eyes Requiring Incisional Intraocular Pressure-Lowering Surgery Following the 0.19-mg Fluocinolone Acetonide Intravitreal Implant.
Journal
Ophthalmic surgery, lasers & imaging retina
ISSN: 2325-8179
Titre abrégé: Ophthalmic Surg Lasers Imaging Retina
Pays: United States
ID NLM: 101599215
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
8
1
2024
Statut:
ppublish
Résumé
To assess ocular, visual, and anatomical outcomes following the 0.19-mg fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN®) and incisional intraocular pressure (IOP)-lowering surgery in diabetic macular edema. From a 36-month, phase 4, open-label, observational study ( Changes at 36 months were +5.4 letters BCVA ( Post-FAc IOP-lowering surgery, regardless of cause, largely did not affect the outcomes measured; these procedures, then, may not meaningfully threaten positive outcomes.
Sections du résumé
BACKGROUND AND OBJECTIVE
UNASSIGNED
To assess ocular, visual, and anatomical outcomes following the 0.19-mg fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN®) and incisional intraocular pressure (IOP)-lowering surgery in diabetic macular edema.
PATIENTS AND METHODS
UNASSIGNED
From a 36-month, phase 4, open-label, observational study (
RESULTS
UNASSIGNED
Changes at 36 months were +5.4 letters BCVA (
CONCLUSIONS
UNASSIGNED
Post-FAc IOP-lowering surgery, regardless of cause, largely did not affect the outcomes measured; these procedures, then, may not meaningfully threaten positive outcomes.
Identifiants
pubmed: 38189802
doi: 10.3928/23258160-20231109-02
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM